A detailed history of Syon Capital LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Syon Capital LLC holds 4,410 shares of CRL stock, worth $740,042. This represents 0.04% of its overall portfolio holdings.

Number of Shares
4,410
Previous 2,158 104.36%
Holding current value
$740,042
Previous $327 Million 110.73%
% of portfolio
0.04%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025

BUY
$145.57 - $178.99 $327,823 - $403,085
2,252 Added 104.36%
4,410 $690 Million
Q2 2025

Aug 14, 2025

BUY
$99.75 - $151.89 $46,882 - $71,388
470 Added 27.84%
2,158 $327 Million
Q1 2025

May 15, 2025

BUY
$150.52 - $190.14 $254,077 - $320,956
1,688 New
1,688 $254 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.54B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Syon Capital LLC Portfolio

Follow Syon Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Syon Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Syon Capital LLC with notifications on news.